Alembic announces Q2 and H1 2025 unaudited financial results

Alembic Limited, a prominent pharmaceutical company, has released its unaudited financial results for the quarter and half-year concluded on September 30, 2025. The results, approved by the board of directors on November 10, 2025, followed a recommendation from the audit committee. This announcement was made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The unaudited financial results, along with the limited review report from the statutory auditors, are available for public access on the company's website and via a provided QR code. Advertisements detailing these results were published in The Indian Express (English Edition) and Financial Express (Gujarati Edition) on November 11, 2025.

These results are crucial for investors and stakeholders seeking to understand Alembic's financial performance during the specified periods. The company has ensured transparency by making the complete financial information readily accessible through its official channels.